文献

J-GLOBAL ID：201702213992771625   整理番号：17A1438815

過去,現在,およびパーキンソン病の将来の疾患:振動麻痺の200周年に関する特別報告【Powered by NICT】

Past, present, and future of Parkinson’s disease: A special essay on the 200th Anniversary of the Shaking Palsy

著者 (56件)： Obeso J.A. (HM CINAC, Hospital Universitario HM Puerta del Sur, Mostoles, Madrid, Spain) ,  Obeso J.A. (Universidad CEU San Pablo, Madrid, Spain) ,  Obeso J.A. (CIBERNED, Madrid, Spain) ,  Stamelou M. (Department of Neurology, Philipps University, Marburg, Germany) ,  Stamelou M. (Parkinson’s Disease and Movement Disorders Department, HYGEIA Hospital and Attikon Hospital, University of Athens, Athens, Greece) ,  Goetz C.G. (Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA) ,  Poewe W. (Department of Neurology, Medical University Innsbruck, Innsbruck, Austria) ,  Lang A.E. (Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J Safra Program in Parkinson’s Disease, Toronto Western Hospital, Toronto, Canada) ,  Lang A.E. (Department of Medicine, University of Toronto, Toronto, Canada) ,  Weintraub D. (Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA) ,  Weintraub D. (Parkinson’s Disease and Mental Illness Research, Education and Clinical Centers (PADRECC and MIRECC), Corporal Michael J. Crescenz Veteran’s Affairs Medical Center, Philadelphia, Pennsylvania, USA) ,  Burn D. (Medical Sciences, Newcastle University, Newcastle, UK) ,  Halliday G.M. (Brain and Mind Centre, Sydney Medical School, The University of Sydney, Sydney, Australia) ,  Halliday G.M. (School of Medical Sciences, University of New South Wales and Neuroscience Research Australia, Sydney, Australia) ,  Bezard E. (Universite de Bordeaux, Institut des Maladies Neurodegeneratives, Centre National de la Recherche Scientifique Unite Mixte de Recherche 5293, Institut des Maladies Neurodegeneratives, Bordeaux, France) ,  Bezard E. (China Academy of Medical Sciences, Institute of Lab Animal Sciences, Beijing, China) ,  Przedborski S. (Departments of Neurology, Pathology, and Cell Biology, the Center for Motor Neuron Biology and Disease, Columbia University, New York, New York, USA) ,  Przedborski S. (Columbia Translational Neuroscience Initiative, Columbia University, New York, New York, USA) ,  Lehericy S. (Institut du Cerveau et de la Moelle epiniere - ICM, Centre de NeuroImagerie de Recherche - CENIR, Sorbonne Universites, UPMC Univ Paris 06, Inserm U1127, CNRS UMR 7225, Paris, France) ,  Lehericy S. (Groupe Hospitalier Pitie-Salpetriere, Paris, France) ,  Brooks D.J. (Clinical Sciences Department, Newcastle University, Newcastle, UK) ,  Brooks D.J. (Department of Nuclear Medicine, Aarhus University, Aarhus, Denmark) ,  Rothwell J.C. (Human Neurophysiology, Sobell Department, UCL Institute of Neurology, London, UK) ,  Hallett M. (Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA) ,  DeLong M.R. (Department of Neurology, Emory University School of Medicine, Atlanta, Georgia, USA) ,  Marras C. (Morton and Gloria Shulman Movement Disorders Centre and the Edmond J Safra Program in Parkinson’s disease, Toronto Western Hospital, University of Toronto, Toronto, Canada) ,  Tanner C.M. (Movement Disorders and Neuromodulation Center, Department of Neurology, University of California-San Francisco, San Francisco, California, USA) ,  Tanner C.M. (Parkinson’s Disease Research, Education and Clinical Center, San Francisco Veterans Affairs Medical Center, San Francisco, California, USA) ,  Ross G.W. (Veterans Affairs Pacific Islands Health Care System, Honolulu, Hawaii, USA) ,  Langston J.W. (Parkinson’s Institute, Sunnyvale, California, USA) ,  Klein C. (Institute of Neurogenetics, University of Luebeck, Luebeck, Germany) ,  Bonifati V. (Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands) ,  Jankovic J. (Parkinson’s Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas, USA) ,  Lozano A.M. (Department of Neurosurgery, Toronto Western Hospital, University of Toronto, Toronto, Canada) ,  Deuschl G. (Department of Neurology, Universitaetsklinikum Schleswig-Holstein, Christian Albrechts University Kiel, Kiel, Germany) ,  Bergman H. (Department of Medical Neurobiology, Institute of Medical Research Israel-Canada, Jerusalem, Israel) ,  Bergman H. (Edmond and Lily Safra Center for Brain Sciences, The Hebrew University, Jerusalem, Israel) ,  Bergman H. (Department of Neurosurgery, Hadassah University Hospital, Jerusalem, Israel) ,  Tolosa E. (Parkinson’s Disease and Movement Disorders Unit, Neurology Service, Institut Clinic de Neurociencies, Hospital Clinic de Barcelona, Barcelona, Spain) ,  Tolosa E. (Department of Medicine, Universitat de Barcelona, IDIBAPS, Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED) Barcelona, Spain) ,  Rodriguez-Violante M. (Movement Disorders Clinic, Clinical Neurodegenerative Research Unit, Mexico City, Mexico) ,  Rodriguez-Violante M. (Instituto Nacional de Neurologia y Neurocirugia, Mexico City, Mexico) ,  Fahn S. (Department of Neurology, Columbia University Medical Center, New York, New York, USA) ,  Postuma R.B. (Department of Neurology, McGill University, Montreal General Hospital, Montreal, Quebec, Canada) ,  Berg D. (Klinik fuer Neurologie, UKSH, Campus Kiel, Christian-Albrechts-Universitaet, Kiel, Germany) ,  Marek K. (Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA) ,  Standaert D.G. (Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama, USA) ,  Surmeier D.J. (Department of Physiology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA) ,  Olanow C.W. (Departments of Neurology and Neuroscience, Mount Sinai School of Medicine, New York, New York, USA) ,  Kordower J.H. (Research Center for Brain Repair, Rush University Medical Center, Chicago, Illinois, USA) ,  Kordower J.H. (Neuroscience Graduate Program, Rush University Medical Center, Chicago, Illinois, USA) ,  Calabresi P. (Neurological Clinic, Department of Medicine, Hospital Santa Maria della Misericordia, University of Perugia, Perugia, Italy) ,  Calabresi P. (Laboratory of Neurophysiology, Santa Lucia Foundation, IRCCS, Rome, Italy) ,  Schapira A.H.V. (University Department of Clinical Neurosciences, UCL Institute of Neurology, University College London, London, UK) ,  Stoessl A.J. (Pacific Parkinson’s Research Centre, Division of Neurology & Djavadf Mowafaghian Centre for Brain Health, University of British Columbia, British Columbia, Canada) ,  Stoessl A.J. (Vancouver Coastal Health, Vancouver, British Columbia, Canada)
資料名： Movement Disorders  (Movement Disorders)
巻： 32  号： 9  ページ： 1264-1310  発行年： 2017年 
JST資料番号： W2689A  ISSN： 0885-3185  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： アメリカ合衆国 (USA)  言語： 英語 (EN)

抄録/ポイント： 本論文では,パーキンソン病の200年をレビューし,要約した。Dr.James Parkinsonの自身の歴史とHeを正確に記述何,今日の視点からの見逃しを含んでいた。パーキンソン今日疾患は,不確実な原因病理論を多病因条件として理解されていない。多くの進展が病態と対症療法に関して発生しているが,決定的に重要な問題が,尚,分解能を待ちである。後者の中で,疾患進行を修正する必要性は,疑いもなく最重要課題である。要約すると,この複数著者論文,振とう麻ひの二百年祭を記念し,何が,現在の状況,達成され,パーキンソン病の解決に向けて進行する方法の歴史的最新の考慮を提供する。Copyright 2017 Wiley Publishing Japan K.K. All Rights reserved. Translated from English into Japanese by JST.【Powered by NICT】

シソーラス用語： ヘリウム ,  対症療法 ,  不確実性 ,  分解能 ,  *Parkinson病 ,  病因 ,  *麻痺性疾患
準シソーラス用語： 疾患進行 ,  病態 , 【Automatic Indexing@JST】

著者キーワード (3件)： 振動麻痺 ,  パーキンソン病 ,  200周年

分類 (1件)： 神経系疾患の薬物療法  (GN05020Y)

タイトルに関連する用語 (4件)： パーキンソン病 ,  疾患 ,  麻痺 ,  報告